389 related articles for article (PubMed ID: 31009666)
1. Cholestatic pruritus: Emerging mechanisms and therapeutics.
Patel SP; Vasavda C; Ho B; Meixiong J; Dong X; Kwatra SG
J Am Acad Dermatol; 2019 Dec; 81(6):1371-1378. PubMed ID: 31009666
[TBL] [Abstract][Full Text] [Related]
2. MRGPRX4 in Cholestatic Pruritus.
Yu H; Wangensteen K; Deng T; Li Y; Luo W
Semin Liver Dis; 2021 Aug; 41(3):358-367. PubMed ID: 34161994
[TBL] [Abstract][Full Text] [Related]
3. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
4. Advances in pathogenesis and management of pruritus in cholestasis.
Kremer AE; Bolier R; van Dijk R; Oude Elferink RP; Beuers U
Dig Dis; 2014; 32(5):637-45. PubMed ID: 25034299
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
6. Cholestatic Itch Management.
Mittal A
Curr Probl Dermatol; 2016; 50():142-8. PubMed ID: 27578083
[TBL] [Abstract][Full Text] [Related]
7. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
de Vries E; Bolier R; Goet J; Parés A; Verbeek J; de Vree M; Drenth J; van Erpecum K; van Nieuwkerk K; van der Heide F; Mostafavi N; Helder J; Ponsioen C; Oude Elferink R; van Buuren H; Beuers U;
Gastroenterology; 2021 Feb; 160(3):734-743.e6. PubMed ID: 33031833
[TBL] [Abstract][Full Text] [Related]
8. Cholestatic pruritus : an update.
De Vloo C; Nevens F
Acta Gastroenterol Belg; 2019; 82(1):75-82. PubMed ID: 30888758
[TBL] [Abstract][Full Text] [Related]
9. Cholestasis-Associated Pruritus and Its Pruritogens.
Langedijk JAGM; Beuers UH; Oude Elferink RPJ
Front Med (Lausanne); 2021; 8():639674. PubMed ID: 33791327
[TBL] [Abstract][Full Text] [Related]
10. Pruritus in cholestasis: facts and fiction.
Beuers U; Kremer AE; Bolier R; Elferink RP
Hepatology; 2014 Jul; 60(1):399-407. PubMed ID: 24807046
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
Beuers U; Wolters F; Oude Elferink RPJ
Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and current management of pruritus in liver disease.
Kremer AE; Oude Elferink RP; Beuers U
Clin Res Hepatol Gastroenterol; 2011 Feb; 35(2):89-97. PubMed ID: 21809485
[TBL] [Abstract][Full Text] [Related]
13. Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments.
Vander Does A; Levy C; Yosipovitch G
Am J Clin Dermatol; 2022 Sep; 23(5):647-659. PubMed ID: 35900649
[TBL] [Abstract][Full Text] [Related]
14. An update on the physiopathology and therapeutic management of cholestatic pruritus in children.
Thébaut A; Debray D; Gonzales E
Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):103-109. PubMed ID: 29031874
[TBL] [Abstract][Full Text] [Related]
15. Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.
Bolier R; de Vries ES; Parés A; Helder J; Kemper EM; Zwinderman K; Elferink RPO; Beuers U;
Trials; 2017 May; 18(1):230. PubMed ID: 28535810
[TBL] [Abstract][Full Text] [Related]
16. MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus.
Meixiong J; Vasavda C; Snyder SH; Dong X
Proc Natl Acad Sci U S A; 2019 May; 116(21):10525-10530. PubMed ID: 31068464
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis.
Dervout C; Boulais N; Barnetche T; Nousbaum JB; Brenaut E; Misery L
Acta Derm Venereol; 2022 Feb; 102():adv00653. PubMed ID: 35088869
[TBL] [Abstract][Full Text] [Related]
18. Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
Smith HT; de Souza AR; Thompson AH; McLaughlin MM; Dever JJ; Myers JA; Chen JV
Dig Dis Sci; 2023 Jun; 68(6):2710-2730. PubMed ID: 36933112
[TBL] [Abstract][Full Text] [Related]
19. IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH.
Xu J; Wang Y; Khoshdeli M; Peach M; Chuang JC; Lin J; Tsai WW; Mahadevan S; Minto W; Diehl L; Gupta R; Trauner M; Patel K; Noureddin M; Kowdley KV; Gulamhusein A; Bowlus CL; Huss RS; Myers RP; Chung C; Billin AN
Hepatology; 2023 Jan; 77(1):20-32. PubMed ID: 35686937
[TBL] [Abstract][Full Text] [Related]
20. [Cholestatic pruritus : new insights into pathophysiology and current treatment].
Kremer AE; Oude Elferink RP; Beuers U
Hautarzt; 2012 Jul; 63(7):532-8. PubMed ID: 22733242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
